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Abstract
Background: Affective dysregulation is widely regarded as being the core problem in patients with borderline
personality disorder (BPD). Moreover, BPD is the disorder mainly associated with affective dysregulation. However,
the empirical confirmation of the specificity of affective dysregulation for BPD is still pending. We used a validated
approach from basic affective science that allows for simultaneously analyzing three interdependent components of
affective dysregulation that are disturbed in patients with BPD: homebase, variability, and attractor strength (return
to baseline).
Methods: We applied two types of multilevel models on two e-diary datasets to investigate group differences
regarding three subcomponents between BPD patients (n = 43; n = 51) and patients with posttraumatic stress disorder
(PTSD; n = 28) and those with bulimia nervosa (BN; n = 20) as clinical control groups in dataset 1, and patients with
panic disorder (PD; n = 26) and those with major depression (MD; n = 25) as clinical control groups in dataset 2. In
addition, healthy controls (n = 28; n = 40) were included in the analyses. In both studies, e-diaries were used to
repeatedly collect data about affective experiences during participants’ daily lives. In study 1 a high-frequency sampling
strategy with assessments in 15 min-intervals over 24 h was applied, whereas the assessments occurred every waking
hour over 48 h in study 2. The local ethics committees approved both studies, and all participants provided written
informed consent.
Results: In contradiction to our hypotheses, BPD patients did not consistently show altered affective dysregulation
compared to the clinical patient groups. The only differences in affective dynamics in BPD patients emerged with
regard to one of three subcomponents, affective homebase. However, these results were not even consistent.
Conversely, comparing the patients to healthy controls revealed a pattern of more negative affective homebases,
higher levels of affective variability, and (partially) reduced returns to baseline in the patient groups.
Conclusions: Our results indicate that affective dysregulation constitutes a transdiagnostic mechanism that manifests
in similar ways in several different mental disorders. We point out promising prospects that might help to elucidate the
common and distinctive mechanisms that underlie several different disorders and that should be addressed in future
studies.
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Background
Affective dysregulation is widely regarded as being the core
problem in patients with Borderline Personality Disorder
(BPD) and the driving force behind the severe clinical mani-
festations of BPD symptoms. This is supported by a magni-
tude of empirical findings relating affective dysregulation to
other BPD symptoms and behaviors [1–3]. The importance
of affective dysregulation is furthermore delineated in the
DSM-5 [4] and the ICD-10 [5], since several diagnostic
criteria for BPD, such as, e.g., affective instability, intense
anger, and chronic feelings of emptiness directly reflect as-
pects of dynamic affective difficulties. In one of the most
highly regarded theories of BPD, the biosocial theory [6], the
affective dysregulation emerges from transactions between
biological vulnerabilities and specific environmental influ-
ences. According to this model the affective dysregulation in
BPD manifests in: (a) a high sensitivity to emotional stimuli
(especially negative ones) resulting in a lower threshold for
responding to those; (b) intense responses to emotional
stimuli, i.e., emotional responses with greater amplitudes;
and in (c) a longer duration of emotional responses and thus
a slow return to baseline after responding to emotional
stimuli. In a nutshell, affective dysregulation is of central
importance in this disorder and has had major impacts on
theory, research, and treatment. However, most recently
Santangelo et al. [7] used an electronic diary approach to
clarify the specificity of affective instability in BPD, and
largely failed. BPD patients showed comparable affective in-
stability to patients with posttraumatic stress disorder
(PTSD) and patients with bulimia nervosa (BN), which
raised the question to consider subcomponents of affective
dynamics.
To further clarify the unsatisfying findings regarding the
specificity of affective instability and to delineate differences
in emotional processes between patients with BPD and clin-
ical controls, Ebner-Priemer et al. [8] proposed the use of
the DynAffect model [9], i.e., a model from basic affective
science. The DynAffect model synthesizes different lines of
basic research on emotion dynamics into one coherent
model with the objective of identifying the major processes
that underlie individual differences in the temporal dynam-
ics of affective experiences [9]. It assumes three components
which characterize individual differences in affect dynamics.
These postulated components can be mapped to the three
subcomponents of affective dysregulation defined in the bio-
social theory of BPD [6] as shown above: (a) affective home-
base, i.e., an individual baseline attractor state around which
affect fluctuates; (b) level of affective variability, i.e., the fluc-
tuations around the homebase that result from responses to
internal or external processes or events; and (c) attractor
strength, i.e., regulatory or homeostatic processes that
pull deviating affective fluctuations back toward the
homebase and thus enables emotional recovery. Dys-
regulated affect can become expressed in several ways
in the three DynAffect components. First, negative devia-
tions from a normative affective homebase that is mildly
positive and aroused [10] can be indicative of affect dysreg-
ulation. Second, high levels of affect variability are related
to lower psychological well-being [11], and are considered
to be, at least to some extent, the result of disrupted emo-
tion regulation [12]. Third, high attractor strength reflects
successful affect regulation with affective experience being
strongly pulled back to the homebase, whereas low at-
tractor strength indicates affect that keeps lingering, sug-
gestive of failing affect regulation efforts [13].
Ebner-Priemer et al. [8] empirically validated the appro-
priateness of the DynAffect model in examining affective
dysregulation in BPD by statistically modeling data from
three e-diary studies containing data of patients with BPD
and healthy subjects. This validation showed strong support
for more negative affective homebases and heightened
affective variabilities as well as partial support of a slower
return to baseline in BPD patients compared to healthy
controls, both with regard to valence as well as distress.
Thus, Ebner-Priemer et al. [8] presented a theoretical
model that captures the most fundamental affective dynam-
ical processes that are supposed to underlie BPD and
showed the usefulness of this model by applying it to mul-
tiple empirical datasets. However, the question regarding
the specificity of the three subcomponents of affective
dysregulation was not addressed in this study, since the
datasets did not include any clinical control groups.
To address the still open question whether affective dys-
regulation is specific for patients with BPD or whether
affective dysregulation rather constitutes a transdiagnostic
feature of several mental disorders, we simultaneously ana-
lyzed the three subcomponents of affective dysregulation
(homebase, variability, and attractor strength). We analyzed
two independent datasets to investigate whether BPD pa-
tients show a specific pattern of affective dysregulation as
proposed by the biosocial theory of BPD [6]. We compared
BPD patients (n = 43 and n = 51) with clinical control
groups consisting of patients with PTSD (n = 28) and with
BN (n = 20) in dataset 1, and patients with panic disorder
(PD; n = 26) and with major depression (MD; n = 25) in
dataset 2. In both studies, e-diaries were used to repeatedly
collect data about affective experiences (valence and distress)
during participants’ daily lives. In study 1 we applied a high-
frequency sampling strategy with assessments of momentary
valence and distress in 15 min-intervals over 24 h during
waking time. In the second study, we utilized a sampling
strategy with repeated assessments of current distress every
waking hour over 48 h. We applied two types of multilevel
models to simultaneously analyze the subcomponents of
affective dysregulation [8] as proposed by the biosocial the-
ory [6]. Due to the predictions derived from the biosocial
theory, we hypothesized (a) a more negative affective home-
base in the BPD group compared to the clinical control
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groups; (b) BPD patients to exhibit heightened affective vari-
ability in comparison to the clinical control groups; and (c)
that the patients with BPD would exhibit reduced attractor
strength (i.e., a higher autocorrelation reflecting a slower
return to baseline) compared to the clinical control groups.
In addition, we included healthy control participants in the
analyses to check robustness of the results.
Methods
Participants: dataset 1
A total sample of 119 female participants between 18 and
48 years of age was investigated: 43 patients with BPD, 28
patients with PTSD, 20 patients with BN and 28 healthy
controls. Data were collected at the Central Institute of
Mental Health Mannheim and the Psychosomatic Clinic St.
Franziska-Stift Bad Kreuznach in Germany. Outpatients and
inpatients were recruited from their outpatient clinics or
wards or via advertisements in local newspapers and on the
internet. The healthy controls were selected randomly from
the national resident register of the City of Mannheim or
recruited via advertisement. The participants’ sample charac-
teristics are summarized in Table 1. For further details about
the dataset, please consult the publication of Santangelo et
al. [7] describing the specific aspects of it. With regard to
this dataset, statistical analyses of other characteristics have
been reported. In details, the specificity of global instability
[7] as well as first analyses regarding subcomponents of
affective dysregulation comparing BPD patients to healthy
controls [8]. However, the main research question of the
current paper, namely if subcomponents of affective dysreg-
ulation show specificity for BPD patients compared to clin-
ical controls, have not been analyzed or reported before.
Participants: dataset 2
Sample 2 consists of 142 female participants between 17
and 50 years of age: 51 BPD patients, 26 PD patients, 25
Table 1 Demographic Characteristics of dataset 1 and dataset 2
Dataset 1 (N = 119) Dataset 2 (N = 142)
BPD
(n = 43)
PTSD
(n = 28)
BN
(n = 20)
HC
(n = 28)
BPD
(n = 51)
PD
(n = 26)
MD
(n = 25)
HC
(n = 40)
Age in years
Mean (Sd) 26.7 (7.1) 35.25 (7.5) 23.70 (6.0) 28.82 (7.5) 27.1 (6.7) 33.1 (8.4) 34.1 (7.8) 27.8 (7.4)
Sex
% female 100 100 100 100 100 100 100 100
Total number of e-diary data entries
Mean (Sd) 57.91 (7.7) 58.50 (8.7) 56.70 (7.7) 56.68 (7.1) 26.3 (3.4) 24.5 (4.0) 23.5 (3.3) 26.0 (3.3)
BPD (n = 43) PTSD (n = 28) BN (n = 20) BPD (n = 51) PD (n = 26) MD (n = 25)
Psychotropic medication
n (%) 16 (37%) 17 (60%) 5 (25%) 22 (43%) 10 (39%) 24 (96%)
Hospitalization
Outpatients n (%) 26 (60%) 8 (29%) 9 (45%) 26 (51%) 21 (81%) 13 (52%)
Inpatients n (%) 17 (40%) 20 (71%) 11 (55%) 25 (49%) 5 (19%) 12 (48%)
Current Axis I diagnoses n (%)
Major depression 9 (21%) 15 (54%) 10 (50%) 17 (33%) 4 (15%) 25 (100%)
Anxiety disorders 27 (63%) 19 (68%) 10 (50%) 35 (69%) 26 (100%) 12 (48%)
Generalized anxiety disorder 6 (14%) 1 (4%) 1 (5%) 8 (16%) 5 (19%) 4 (16%)
Panic disorder 14 (33%) 10 (36%) 2 (10%) 13 (26%) 26 (100%) 2 (8%)
Agora phobia 3 (7%) 0 (0%) 2 (10%) 4 (8%) 23 (89%) 1 (4%)
Other phobias 20 (47%) 15 (54%) 9 (45%) 16 (31%) 5 (19%) 6 (24%)
Posttraumatic stress disorder 22 (51%) 28(100%) 3 (15%) 7 (14%) 0 (0%) 6 (24%)
Obsessive-compulsive disorder 5 (12%) 0 (0%) 1 (5%) 6 (12%) 0 (0%) 2 (8%)
Eating disorders 14 (33%) 20 (71%) 20 (100%) 18 (35%) 0 (0%) 1 (4%)
Current Axis II disorders n (%)
Cluster A 7 (16%) 3 (11%) 1 (5%)
Cluster B (besides BPD diagnosis) 3 (7%) 0 (0%) 1 (5%)
Cluster C 26 (61%) 8 (29%) 4 (20%)
BPD Borderline Personality Disorder, PTSD Posttraumatic Stress Disorder, BN Bulimia Nervosa, PD Panic Disorder, MD Major Depression, HC Healthy Controls
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MD patients and 40 healthy controls. Data were collected
at the Freiburg University Medical School and at the Free
University of Berlin, both located in Germany. Outpatients
and inpatients were recruited from their outpatient clinics
and private practices or wards, respectively. The healthy
controls were randomly selected from the national resident
register of the City of Freiburg. The sample characteristics
are shown in Table 1. For a more detailed description of
the dataset, please consult the publication of Stiglmayr et
al. [14]. There are no previous publications on this data set
with regard to affective instability or affective dysregulation
as in dataset 1.
Diagnostic procedure: dataset 1 and 2
All patients met the DSM-IV criteria for their specific
disorder. In both samples, Axis I disorders were assessed
using the German version of the Structured Clinical
Interview for DSM-IV Axis I Disorders (SCID-I; [15]),
and Axis II disorders were assessed using the German
versions of the International Personality Disorder Exam-
ination (IPDE; [16]) in dataset 1 and the BPD section of
the Structured Clinical Interview for DSM-IV Axis II
Disorders (SCID-II; [17]) in dataset 2, respectively. In
the healthy control group, the absence of any current or
past Axis I or Axis II disorder diagnoses was confirmed
by the SCID-I and SCID-II. Trained postgraduate psy-
chologists administered all diagnostic instruments. In
the patient groups, a history of schizophrenia or bipolar
disorder or current substance abuse constituted exclu-
sion criteria. Furthermore, patients of the clinical control
groups who met the criteria for BPD were excluded in
both studies. All other comorbidities were allowed in the
patient groups. The exclusion criteria for the healthy
controls included any current or past Axis I or Axis II
disorder diagnoses, self-reported current psychotherapy,
or the current use of psychotropic medications. As Table 1
shows, patients with BPD had very high rates of comorbid
Axis I disorders, particularly eating disorder, anxiety disor-
ders, and depressive disorders in both datasets. Whereas
patients with PTSD and those with BN had similar high
rates of comorbid eating, anxiety, and depressive disorders
in dataset 1, the patients with PD and those with MD had
lower rates of comorbidities, at least with regard to eating
disorders in dataset 2.
Data collection procedure: datasets 1
All participants provided written informed consent prior
to participation in the study, which has been approved
by the local ethics committee. Participants were carefully
instructed and trained regarding the use of the palmtop
computer (Tungsten E, Palm Inc., U.S.A.). To function as
e-diaries the palmtop computers were programmed with
the DialogPad software (Gerhard Mutz, Cologne University,
Germany). Subsequent to the training session, participants
carried the e-diary for 24 h. The e-diary emitted a prompt-
ing signal every 15 min (±1 min) during the waking time.
Questions regarding the participants’ current emotions
followed each prompt. Participants were asked “Do you feel
any of the following emotions right now?” followed by the
list of happy, anxious, angry, shame, disgust, sad, guilt,
interest, envy/jealousy, emotion but cannot name it, and no
emotion. After selecting a current emotional state, partici-
pants rated the intensity of this emotion on an 11-point
Likert scale ranging from 1 to 11. In case that “emotion but
cannot name it” was chosen, an additional question was
added concerning the pleasantness of the current emotion
(pleasant or unpleasant) followed by the intensity rating. In
addition, participants rated their current intensity of dis-
tress on an 11-point Likert scale from 0 to 10. After the 24-
h assessment period participants returned the device and
the data were downloaded from the e-diaries.
Data collection procedure: datasets 2
The local ethics committees approved the study, and all
participants provided written informed consent before
participating. Participants attended an orientation session
to get familiar with the use of the palmtop computer
(Psion 3a, Psion PLC, United Kingdom). The palmtop
computers were programmed with the MONITOR soft-
ware [18] to emit a prompting signal in hourly intervals
(±5 min). Participants carried the e-diary over a 48-h
period and were prompted every hour during waking time
to provide information regarding their current subjective
distress experience on a single 10-point Likert scale ran-
ging from 0 to 9. After the 48-h assessment period partici-
pants returned the devices and the data were downloaded
from the e-diaries.
Compliance: dataset 1 and 2
Compliance in both datasets was very high (94% and 92%,
respectively). Participants in dataset 1 provided on average
57.55 (Sd = 7.77; Median = 57) self-reports, whereas partici-
pants in dataset 2 provided on average 25.37 (Sd = 3.58;
Median = 26) momentary assessments (Table 1; for a more
detailed description of compliance see Santangelo et al. [7]
for dataset 1 and Stiglmayr et al. [14] for dataset 2).
Data preprocessing and statistical analyses
Data preprocessing
To aggregate the separate assessments of emotion and in-
tensity into a single valence index in dataset 1, the inten-
sities of negative emotions were multiplied by −1, and the
intensities of the positive emotions retained positive values
[7]. This method resulted in valence scores with a range of
−11 to +11. Ratings of “no emotion” were given valence
scores of zero. Thus, the two dependent variables used in
the statistical analyses were (a) valence (with possible
values ranging from −11 to +11) and (b) distress (with
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possible values ranging from 0 to 10). No data preprocess-
ing was necessary in dataset 2. Possible values of distress
as the dependent variable ranged from 0 to 9.
For the subcomponents analysis of distress, data from
one BPD patient and one PTSD patient and eight healthy
controls were excluded from the analyses due to lack of
variability or linear trend in their ratings in dataset 1. The
final sample for this analysis consisted of 42 BPD patients,
27 patients with PTSD, 20 patients with BN and 20 healthy
controls. No participants were excluded in the analysis of
valence in this dataset. In dataset 2, two patients with MD
and seven healthy controls were excluded from the analyses
due to lack of variability in their distress ratings. Thus, the
final sample consisted of 51 BPD patients, 26 patients with
PD, 23 patients with MD and 33 healthy controls.
Statistical analyses
We used multilevel modeling to analyze the three subcom-
ponents of affective dysregulation: (a) affective homebase
(i.e., one’s affective baseline state), (b) affective variability
(i.e., the total sum of the fluctuations around the affective
homebase in response to internal or external events), and
(c) attractor strength (i.e., the regulatory processes that pull
affect back to its homebase or return to baseline). These
statistical approaches were used to simultaneously model
the three different parameters and to investigate how these
parameters differed as functions of group (BPD vs. PTSD
vs. BN and BPD vs. PD vs. MD, respectively).
The main analyses were performed using HLM [19].
To test our hypotheses, a total of three models with the
BPD group as the reference group were tested (i.e., one
model with valence and one with distress as outcome
variables in dataset 1 and one model with distress as the
outcome variable in dataset 2). The multilevel regression
analyses models were defined as follows (with the BPD
patients as the reference group):
Level 1 equation:
distressti ¼ π0i þ π1i  distressðt−1Þi þ eti
Level 2 equation:
π0i ¼ β00 þ β01  ðPTSDiÞ þ β02  ðBNiÞ þ r0i
π1i ¼ β10 þ β11  ðPTSDiÞ þ β12  ðBNiÞ þ r1i
VarðRÞ ¼ σ2and logðσ2Þ ¼ α0 þ α1ðPTSDiÞ þ α2ðBNiÞ
where distressti corresponds to the distress rating for
person i at time t. At level 1, distressti is predicted by a
random intercept and a time-lagged version of itself (i.e.,
distress(t-1)i). This variable has been centered around the
person mean (i.e., within-person centered) and previous-
day observations were set as missing to exclude day-to-
day carry-over effects. The random slope of this lagged
variable, π1i, is the autoregressive effect of distress(t-1)i
on distressti. At level 2, the random intercept and slope
are both predicted by an intercept and two dummy vari-
ables coding for the clinical control groups. The equa-
tion shown is the multilevel model comparing the BPD
group (as the reference group it is not represented by a
dummy variable) to the PTSD group and the BN group. β00
corresponds to the mean distress, i.e., the distress home-
base, in the BPD group (when the PTSD and BN dummies
are equal to zero). Similarly, β10 corresponds to the mean
autoregressive slope, i.e., the return to baseline, in the BPD
group (when the two dummy coded group variables are
zero). Simultaneously, the within-person variance is mod-
eled as a function of the two dummy variables. For the
examination of valence, distressti was replaced by valenceti
(dataset 1). For the analyses in dataset 2 the dummy vari-
ables coding for the clinical groups were replaced (i.e.,
PTSDi and BNi were replaced by PDi and MDi). Addition-
ally, we estimated three models with the same outcome
variables, this time examining general differences between
healthy controls and clinical groups. More specifically, we
estimated a multilevel model with the healthy controls as
the reference group and a dummy coding for all patients
taken together (i.e., the healthy controls vs. BPD+ PTSD +
BN in dataset 1, and the healthy controls vs. BPD+ PD+
MD in dataset 2, respectively).
Last, in order to enable the identification of consistent
patterns of results and to allow for robust conclusions
we repeated all analyses with slightly different models
and in a different statistical framework. These models
are extensions of the models used before, in that not
only the intercept and the autoregressive slope but also
the within-person variance was estimated as a random
effect. In other words, we allowed for individual differ-
ences in within-person variances, while the models de-
scribed above assume that the within-person variance is
homogenous within diagnostic groups. The statistical
inference for these models was done using Bayesian
statistics instead of the frequentist statistical approach
that is adopted in the models described above. Bayesian
statistics requires the specification of priors. For each per-
son the model has a person-specific intercept, slope and
within-person variance (the latter is log-transformed). The
triplet of person-specific parameters is assumed to come
from a trivariate normal population distribution. This tri-
variate distribution has a population mean for each par-
ameter that may differ across the clinical groups. We used
dummy coding schemes to incorporate these group differ-
ences. Both for the reference group mean as for the devia-
tions of the other groups, we assumed as priors relative
vague normal distributions with mean being zero and
variance being 1000 (for the autocorrelation, the normal
prior distributions were truncated at −1 and 1). The
variance-covariance matrix of the trivariate normal distri-
bution was the same for all groups and its prior was an
inverse-Wishart with an identity matrix as scale matrix
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and four degrees of freedom. The Bayesian analyses were
implemented in JAGS [20]. We used four chains with a
burn-in period of 5000 iterations. The subsequent 2500
iterations from each chain were used for inference (no
thinning). Convergence of the chains was checked for the
different parameters visually (i.e., by looking at the trace
plots and the autocorrelation graphs), and numerically
(i.e., by calculating the shrink factor) [21, 22]. The trace
plots were stationary time series, and they overlapped for
different chains, while the autocorrelation plots did not
indicate any strong autocorrelation. For all parameters,
the shrink factor was very close to 1 (and always below
1.1). Taken together, these diagnostics suggest good con-
vergence. Moreover, based on these additional models
applied in the Bayesian framework we also constructed
density plots (see Fig. 1a, b, and c). For each specific par-
ameter (i.e., homebase, variability, and attractor strength),
we first estimated the posterior mean per person and then
we made a density plot for each group based on these pos-
terior means, showing the (posterior) distributions of the pa-
rameters of interest for each investigated group separately.
Results
Subcomponent affective homebase
Results from the multilevel regression models are shown
in Table 2. These indicated that the distress level of the
homebase of the BPD patients was comparable to that of
the PTSD and BN patients in dataset 1 (HOMEBASE,
π0, Table 2). BPD patients and those with PTSD also had
homebases characterized by similar levels of unpleasant-
ness, whereas the BPD patients had a homebase that
was marginally significantly more negative compared to
the BN patients. Using multilevel models applied in the
Bayesian framework, no differences were found between
BPD and the clinical groups for both the valence and the
distress dimension of the homebase (i.e., the marginally
significant difference between the BPD and the BN pa-
tients with regard to valence was not robust). In dataset 2,
the BPD patients had a homebase with significantly higher
distress levels compared to the PD and MD patients,
which was confirmed by the models applied in the Bayes-
ian framework.
Moreover, patients showed a homebase with significantly
higher levels of distress compared to healthy controls in
dataset 1 and 2 (HOMEBASE, π0, Table 3). Furthermore,
the healthy controls tended to have a pleasant valence
homebase, whereas the clinical groups, patients with BPD,
those with PTSD and those with BN were, on average,
characterized by a significantly more unpleasant or negative
valence homebase in dataset 1. All results were in line with
the conclusions from the multilevel models with Bayesian
inference.
The distributions of the affective homebase parameters
for all groups in dataset 1 and 2 are depicted in the density
plots shown in Fig. 1a. Descriptively, the impressive differ-
ences between the healthy controls and the clinical groups
hit the eye in all three figures of Fig. 1a. For healthy con-
trols the plots are more located to the left for distress in
both datasets (indicating lower distress levels), and more to
the right for valence (reflecting a more positive homebase).
Moreover, the estimates are more homogenous within the
healthy control sample, as the plots are less wide. In con-
trast, only minor differences among the clinical groups
seem to emerge, with the only exception of the distribution
of the homebase parameters for distress in dataset 2. The
plot for the BPD patients is located more to the right and is
broader, reflecting higher levels of distress and more het-
erogeneity within the BPD sample.
Subcomponent within-person variability
Results showed that the within-person variability (VARI-
ANCE, Table 2) of distress in the BPD patients was com-
parable to that of the PTSD patients (dataset 1) and the PD
and MD patients (dataset 2). The BN patients in dataset 1
had a significantly elevated variability of distress compared
to the BPD patients, albeit this significant difference was
not robust (since the results of the models with Bayesian
inference indicated no difference of within-person variabil-
ity of distress between BN and BPD patients). With regard
to the variability of valence no significant differences be-
tween BPD patients and PTSD or BN patients was evident,
which was supported by the results of the multilevel models
with Bayesian inference.
The results for the variability of distress and valence
revealed significant differences between healthy controls
and all patient groups. Patients with BPD and those with
PTSD and with BN showed significantly higher within-
person variability of distress as well as valence compared
to healthy controls in dataset 1 (VARIANCE, Table 3).
Heightened variability in distress compared to the healthy
subjects was also found in patients (those with BPD, those
with PD and those with MD) in dataset 2. Again, these re-
sults were in line with the conclusions from the multilevel
models with Bayesian inference.
On a descriptive basis, clear differences emerged be-
tween the healthy controls and the clinical groups in the
density plots in Fig. 1b. The density plots for the healthy
controls are again located more to the left, reflecting lower
average within-person variance for this group. However, the
differences between the clinical groups seem negligible.
Subcomponent attractor strength (return to baseline)
No differences emerged comparing the attractor strength
between the clinical groups, neither between the BPD
group and the PTSD and BN patients (dataset 1) nor be-
tween the BPD group and the PD and MD patients (data-
set 2) and neither regarding attractor strength in distress
nor valence (AUTOREGRESSIVE slope, π1, Table 2).
Santangelo et al. Borderline Personality Disorder and Emotion Dysregulation  (2016) 3:5 Page 6 of 13
ab
c
Fig. 1 (See legend on next page.)
Santangelo et al. Borderline Personality Disorder and Emotion Dysregulation  (2016) 3:5 Page 7 of 13
The results regarding attractor strength of distress indi-
cate a significantly lower autoregressive slope (i.e., higher
attractor strength and thus faster return to baseline) in the
healthy controls compared to BPD, PTSD and BN patients
(AUTOREGRESSIVE slope, π1, Table 3) in dataset 1. The
result from the model with Bayesian inference is in line
with this finding. In dataset 2, marginally significantly
higher attractor strength in distress was found in the
healthy controls when compared to the patient groups.
However, this difference was not found in the models
applied in the Bayesian framework. For valence, we only
found marginally significantly higher attractor strength for
healthy controls in comparison to the patient groups.
Again, this difference was not found in the models with
Bayesian inference.
The density plots for the attractor strength component
are not as clear as those for the other two components,
since the distributions of the healthy controls do not seem
to clearly stand out (see Fig. 1c). The only exception is the
plot for the attractor strength parameter for distress in
dataset 1, since the distribution for healthy controls is
slightly more located to the left (indicating higher attractor
strength). With regard to differences between the clinical
groups, there are only slight differences between the distri-
butions of the attractor strength estimates.
Discussion
To further clarify the specificity of affective dysregulation
in BPD, we used a recently proposed model of affective
dynamics (the DynAffect model) simultaneously modeling
three central subcomponents of affective dysregulation
(homebase, variability, and attractor strength). Contrary to
our expectations, BPD patients did not consistently show
a specific pattern of affective dysregulation compared to
other clinical groups (i.e., patients with PTSD, with BN,
with PD and with MD). Therefore, our results indicate
that affective dysregulation is, apart from very few excep-
tions, not very specific for BPD, as the clinical groups
tended to show similar results. In dataset 1 we found no
robust differences (i.e., consistent differences between the
groups in both types of multilevel analyses) neither re-
garding the distress level of the homebases nor the valence
(See figure on previous page.)
Fig. 1 Density plots based on the models applied in the Bayesian framework. The plots depict the distributions of the posterior mean estimations of
the three coefficients corresponding to the components of affective dysregulation with regard to distress and valence. Distributions of the respective
coefficient estimates (coefficient intercept corresponding to the subcomponent affective homebase in a, coefficient within-variance corresponding to the
subcomponent within-person variability in b, and coefficient autocorrelation corresponding to the subcomponent attractor strength in c) are shown for
each investigated group separately for dataset 1 (patients with borderline personality disorder [BPD], those with posttraumatic stress disorder [PTSD],
those with bulimia nervosa [BN] and healthy controls [HC]) and dataset 2 (patients with borderline personality disorder [BPD], those with
panic disorder [PD], those with major depression [MD] and healthy controls [HC])
Table 2 Estimates from multilevel models for the three subcomponents of affective dysregulation with patients with borderline
personality disorder as the reference group
Dataset 1 Dataset 2
Distress Valence Distress
Coeff. SE Test
statistic
df p Coeff. SE Test
statistic
df p Coeff. SE Test
statistic
df p
For HOMEBASE, π0 For HOMEBASE, π0
Intercept, β00 4.91 0.284 17.28 86 <.001 –2.59 0.410 –6.33 88 <.001 Intercept, β00 4.66 0.275 16.92 97 <.001
PTSDi, β01 –0.23 0.497 –0.46 86 .65 0.50 0.743 0.68 88 .50 PDi, β01 –2.06 0.373 –5.54 97 <.001
BNi, β02 –0.71 0.552 –1.29 86 .20 1.43 0.759 1.88 88 .06 MDi, β02 –1.30 0.415 –3.15 97 <.001
For VARIANCE For VARIANCE
Intercept, α0 1.22 0.032 38.32 <.001 3.14 0.031 99.65 <.001 Intercept, α0 1.05 0.044 23.90 <.001
PTSDi, α1 –0.03 0.050 –0.70 .48 –0.06 0.049 –1.31 .19 PDi, α1 0.02 0.078 0.24 .81
BNi, α2 0.19 0.056 3.41 <.001 0.08 0.056 1.44 .15 MDi, α2 0.09 0.084 1.12 .26
For AUTOREGRESSIVE
slope, π1
For AUTOREGRESSIVE
slope, π1
Intercept, β10 0.46 0.036 12.51 86 <.001 0.33 0.034 9.48 88 <.001 Intercept, β10 0.26 0.038 6.87 97 <.001
PTSDi, β11 –0.02 0.052 –0.35 86 .73 0.04 0.056 0.63 88 .53 PDi, β11 –0.04 0.064 –0.58 97 .56
BNi, β12 0.04 0.048 0.86 86 .39 –0.04 0.057 –0.71 88 .48 MDi, β12 0.08 0.076 1.09 97 .28
PTSD Posttraumatic Stress Disorder, BN Bulimia Nervosa, PD Panic Disorder, MD Major Depression
Bolded values = significant difference supported by the result of the multilevel model with Bayesian inference
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dimension of the homebases of the BPD patients and the
PTSD and BN patients. Furthermore, we did not find con-
sistent results regarding elevated affective variability nor
slower return to baseline in the BPD patients compared to
either patient group, i.e., PTSD and BN patients (dataset
1) or PD and MD patients (dataset 2). The only robust ex-
ception (i.e., with consistent findings in both types of
multilevel models) where patients with BPD showed al-
tered affective dynamics compared to the clinical controls
was: the BPD patients had a homebase with significantly
higher levels of distress compared to the PD and the MD
patients (dataset 2). Thus, the only differences emerged
with regard to one of three subcomponents. Furthermore,
the results regarding the homebase component were not
perfectly consistent, since: (a) differences regarding the
distress dimension of the homebase were only found in
dataset 2 (i.e., the PD and the MD patients), but not in
dataset 1 (i.e., the PTSD and BN patients); and (b) no dif-
ferences regarding the valence dimension of the homebase
emerged. Taken together, our results do not show specifi-
city of affective dysregulation regarding several compo-
nents of affective dysregulation (i.e., homebase, variability,
and attractor strength) for patients with BPD. Instead, our
results can be interpreted as further empirical evidence
for affective dysregulation manifesting in similar ways in
several different disorders that are characterized by
affective disturbances.
Of course, BPD is the disorder mainly associated with
affective dysregulation and there is even a BPD journal
with emotion dysregulation it its title. However, there are
multiple theoretical conceptualizations which associate a
variety of mental disorders with affective dysregulation, i.e.,
some kind of burdensome affective experience, deficient
affect regulation, or dysfunctional affect regulation behav-
ior [23–27]. This is in line with the idea that affect regula-
tion is an essential component to mental health [9, 28] and
an important risk and maintaining factor in various mental
disorders [29], and that affect regulation strategies are in-
cluded as treatment modules across numerous disorders,
e.g., eating disorders [30, 31], depressive disorders [32],
and PTSD [33]. Taken together, these results might be
interpreted as an indication that affective dysregulation
rather constitutes a transdiagnostic feature that emerges in
several mental disorders. Moreover, the differences be-
tween the patient groups and the healthy controls regard-
ing all three subcomponents of affective dysregulation are
greatly consistent, both for distress and valence. In a similar
vein, prior studies investigating the specificity of affective
instability for BPD revealed mixed findings regarding height-
ened instability in BPD compared to clinical controls. While
several diary studies found heightened affective instability in
BPD compared to patients with depressive disorders [34–
36], no differences were found between BPD patients and
patients with PTSD [7], those with BN or with anorexia
nervosa [7, 37], patients with premenstrual dysphoric syn-
drome [34], or other personality disorders [38]. Therefore,
global instability indices were not able to clearly differentiate
the clinical groups and thus instability did not show suffi-
cient specificity. Due to the unexpected nature of these find-
ings analyzing subcomponents of the dynamic processes in
order to delineate existing differences in emotional processes
between patients with BPD and clinical controls has been
proposed recently [7, 8]. However, this could not resolve in-
consistencies as we have shown in the present paper. Thus,
even though we used state of the art assessment (e-diaries)
and analytic methods (multilevel modeling) as well as two
comprehensive datasets (N= 119 and N= 142) we did not
find clear group differences regarding the subcomponents of
affective dysregulation between BPD patients and patients
with PTSD, those with BN, those with PD and those with
MD as clinical control groups.
As we can exclude with reasonable certainty that sub-
component analyses reveal specificity of affective dysregula-
tion for BPD there are, on a methodological level, two
more main topics that should be considered to differentiate
affective processes between disorders [7, 26]: (a) events and
triggers of emotional episodes are rarely assessed, but are
very likely to differ between disorders (a notable exception
in BPD is [39]). E.g., tempting food might trigger affective
processes in patients with BN, but not in patients with
PTSD, whereas for traumatic memories the opposite pat-
tern might be expected. Moreover, context plays a central
role in emotion regulation [40, 41]. Therefore, contextual
factors should be systematically incorporated into the study
of emotion dysregulation in future studies.; (b) the appraisal
of affective processes might be worthy of examination, since
affective changes that are accompanied by changes in self-
esteem (a further diagnostic criterion for BPD) might be
experienced as more threatening [7]. Thus, the association
between affective instability and self-esteem instability in
patients with BPD might differ (and therefore be specific
for BPD) from those with other psychiatric disorders. This
association between affective dysregulation and self-esteem
instability in patients with BPD and those with other psy-
chiatric disorders should be investigated in future studies.
On top of that, undifferentiated affect or emotional
granularity has been discussed as being an essential com-
ponent of the affect regulation process [42, 43]. However,
its potential to show specificity of altered affect in BPD
patients seems rather limited, since a recent study showed
that the experience of undifferentiated affect probably con-
stitutes a transdiagnostic mechanism and might be likely
relevant to a range of disorders [44].
Limitations and methodological particularities
Some limitations of our study should be mentioned. We
used electronic diaries to investigate affective dysregula-
tion in participants’ everyday lives. This comes along
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with the disadvantage that the control of confounding
variables is limited. Even though laboratory studies offer
the possibility of testing hypotheses under the most rigor-
ous control, they nonetheless do so under artificial, labora-
tory conditions, which may account for differences
between the laboratory and real life [45–47]. Investigating
affective dysregulation in everyday life has the crucial ad-
vantage that it renders experimental symptom induction
unnecessary: it is studied in the context where it naturally
occurs, in patients’ everyday life [48]. Studies that have
examined affective dysregulation in BPD in the laboratory
have produced inconsistent findings, which might be ex-
plained by the affect induction methods used in these stud-
ies [8]. A further advantage of e-diary assessments is that
retrospective single assessments such as questionnaires or
interviews are not suited to investigate dynamic processes,
such as affective dysregulation [26, 48–51]. By utilizing e-
diary methods one can repeatedly assess the variable of
interest in real time and therefore actually track the ebb
and flow of affective states.
When investigating affective dynamics using e-diaries, it
is of primary importance that the sampling rate matches
the temporal dynamics of the underlying target process [26,
48, 52]. Both a sampling rate that is too infrequent (which
might miss the dynamics of interest) as well as a sampling
rate that is too frequent (which might overburden partici-
pants without increasing insights since the information is
irrelevant) is problematic [53]. Even though guidelines
regarding the sampling frequency are rare, there is a general
consensus that the sampling interval must fit the temporal
dynamics of the target processes [52, 54]. In our two data-
sets the time-based designs differed. Assessments occurred
every 15 min in datasets 1, and every hour in dataset 2.
Since the conclusions were largely similar across both data-
sets, the assessment methods do not seem to have substan-
tially influenced the results. Moreover, we are confident
that both sample designs were appropriate to assess the
affective dynamics, since it has been empirically shown that
a sampling interval of less than 1 h captures a specific
process, whereas the data yielded by low frequency sam-
pling rates (i.e., 2 h intervals and longer) cannot be distin-
guished from random data [52].
Even though both the assessment method and the
sample frequencies are appropriate to investigate affective
dynamics, the cross-sectional design of study 1 and 2 ren-
ders it impossible to evaluate the importance of the
affective dysregulation in the long term. We determined
the three subcomponents of affective dysregulation only
during 24 h and 48 h, respectively. Thus, we got only a
snapshot of affective dysregulation. This is adequate to
analyze group differences regarding affective dysregula-
tion; however, it is inappropriate to investigate potential
associations between affective dysregulation and long term
variables, such as level of functioning and symptom
severity, psychopathology, or treatment outcome.
Therefore, longitudinal studies allowing for the investi-
gation of the predictive value of affective dysregulation
are clearly needed.
A further limitation is the rather small sample sizes of
the clinical control groups in both datasets. Even though
both datasets were extensive (N= 119 and N= 142, re-
spectively), this was mainly due to large group sizes of
the BPD patients and the healthy controls. With regard
to the clinical groups, the group sizes of 28 patients with
PTSD, 20 patients with BN and 26 PD patients and 25
MD patients are low and larger sample sizes are needed
to replicate findings. However, prior studies analyzed
group differences based on as small group sizes as 15
patients with BPD and four patients with anorexia ner-
vosa [37], or 16 patients with BPD, 10 patients with MD
and 15 patients with premenstrual dysphoric syndrome
[34]. Moreover, the patient groups in both datasets dif-
fered in their hospitalization rates. However, no differ-
ences in symptom severity between hospitalized and
non-hospitalized patients emerged (see Santangelo et al.
[7] for dataset 1 and Stiglmayr et al. [14] for dataset 2).
Furthermore, because only female participants were in-
cluded in both datasets, the generalizability of the find-
ings is constrained and the results may not be valid for
male BPD patients. However, the use of a pure female
sample also reduced heterogeneity, which may be useful
given the literature on sex differences on affect [55]. In
study 1 and 2 BPD diagnoses were made using different
diagnostic instruments, i.e., IPDE [16] in study 1 and
SCID-II [17] in study 2. However, both diagnostic instru-
ments are well-validated with very good psychometric
properties and good interrater reliability [16, 17]. More-
over, the two datasets were analyzed separately and inde-
pendently, thus, diagnoses and group comparisons are
valid within each study. Patients, especially BPD patients,
in both datasets were diagnosed with a variety of comorbid
disorders. Given the finding that comorbidity might alter
affective dysregulation [56] no statement can be made on
whether our findings are independent of any comorbidity.
However, in BPD comorbidity is the rule rather than the
exception [57] and therefore, only BPD patients with co-
morbid disorders are seen as representative for the BPD
population [58].
Conclusions
In summary, using sophisticated behavioral science re-
search methodology and validated analytic techniques we
were unable to reveal a specific pattern of affective dysregu-
lation in patients with BPD compared with clinical controls
(i.e., patients with PTSD, those with BN, those with PD or
those with MD). Even though affective dysregulation is
widely regarded as being the core problem in patients with
BPD and BPD being the disorder mainly associated with
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affective dysregulation, our results are in accordance with
clinical observations and reports that most psychological
disorders show some kind of affective dysregulation. Taken
together, these findings suggest that affective dysregulation
might be an important clinical characteristic of several
disorders, in the sense of a transdiagnostic symptom or
risk factor. Nonetheless, the possibility of evaluating the
importance of a construct such as affective instability in a
cross-sectional study is clearly restricted. Longitudinal
studies allowing for the investigation of the predictive
value of affective dysregulation might reveal group differ-
ences. Thus, even though affective instability does not show
specificity for BPD it might be the case that it can be used
to predict symptom severity, psychopathology, or treatment
outcome in BPD whereas it might be of minor relevance in
other patient groups. Addressing the association between
affective dysregulation and self-esteem instability or events
and triggers of emotional episodes in patients with BPD
and those with other psychiatric disorders constitute
auspicious approaches for future studies in order to reveal
specific patterns of symptom expression in BPD.
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